Published 6 August 2009, doi:10.1136/bmj.b3186
Cite this as: BMJ 2009;339:b3186

Editor's Choice

An embarrassment of riches

Trish Groves, deputy editor

1 BMJ

tgroves@bmj.com

The first 150 words of the full text of this article appear below.

At what age should women start having cervical screening? In England screening begins at 25, but elsewhere in the United Kingdom it’s offered from the age of 20. Campaigners have questioned this since the death in February from cervical cancer of the reality television star Jade Goody, who was 27, and at last month’s BMA annual conference 68% of voters called to lower the screening age in England.

Now a large population based study across the UK has provided compelling evidence to support the English stance (doi:10.1136/bmj.b2968). Peter Sasieni and colleagues found that although screening was associated with a 60% reduction of cancers in women aged 40, increasing to 80% at age 64, there was no evidence that screening women aged 22-24 reduced the incidence of cervical cancer over the next five years. While 73 women in this youngest group had cervical cancers, only five could be attributed . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Articles

Cytological surveillance compared with immediate referral for colposcopy in management of women with low grade cervical abnormalities: multicentre randomised controlled trial
TOMBOLA Group
BMJ 2009 339: b2546. [Abstract] [Full Text] [PDF]

Biopsy and selective recall compared with immediate large loop excision in management of women with low grade abnormal cervical cytology referred for colposcopy: multicentre randomised controlled trial
TOMBOLA Group
BMJ 2009 339: b2548. [Abstract] [Full Text] [PDF]

Options for managing low grade cervical abnormalities detected at screening: cost effectiveness study
TOMBOLA Group
BMJ 2009 339: b2549. [Abstract] [Full Text] [PDF]

Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study
Philip E Castle, Ana Cecilia Rodríguez, Robert D Burk, Rolando Herrero, Sholom Wacholder, Mario Alfaro, Jorge Morales, Diego Guillen, Mark E Sherman, Diane Solomon, Mark Schiffman, and for the Proyecto Epidemiológico Guanacaste (PEG) Group
BMJ 2009 339: b2569. [Abstract] [Full Text] [PDF]

Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data
Peter Sasieni, Alejandra Castanon, and Jack Cuzick
BMJ 2009 339: b2968. [Abstract] [Full Text] [PDF]

Managing low grade and borderline cervical abnormalities
Eduardo L Franco
BMJ 2009 339: b3014. [Extract] [Full Text]




Access jobs at BMJ Careers
Whats new online at Student 

BMJ